Terms: = Germ cell tumor AND Neurokinin AND Treatment
38 results:
1. The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma.
Ebrahimi S; Mirzavi F; Hashemy SI; Khaleghi Ghadiri M; Stummer W; Gorji A
Biofactors; 2023; 49(4):900-911. PubMed ID: 37092793
[TBL] [Abstract] [Full Text] [Related]
2. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi
Suthiram J; Pieters A; Mohamed Moosa Z; Zeevaart JR; Sathekge MM; Ebenhan T; Anderson RC; Newton CL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768456
[TBL] [Abstract] [Full Text] [Related]
3. The neurokinin-1 Receptor Is Essential for the Viability of Human Glioma cells: A Possible Target for Treating Glioblastoma.
Muñoz MF; Argüelles S; Rosso M; Medina R; Coveñas R; Ayala A; Muñoz M
Biomed Res Int; 2022; 2022():6291504. PubMed ID: 35434136
[TBL] [Abstract] [Full Text] [Related]
4. Novel NK1R-Targeted
Matalińska J; Kosińska K; Halik PK; Koźmiński P; Lipiński PFJ; Gniazdowska E; Misicka A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163139
[TBL] [Abstract] [Full Text] [Related]
5. Substance P containing peptide gene delivery vectors for specifically transfecting glioma cells mediated by a neurokinin-1 receptor.
Ding G; Wang T; Han Z; Tian L; Cheng Q; Luo L; Zhao B; Wang C; Feng S; Wang L; Meng Z; Meng Q
J Mater Chem B; 2021 Aug; 9(32):6347-6356. PubMed ID: 34251002
[TBL] [Abstract] [Full Text] [Related]
6. neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the treatment of Glioblastoma Multiforme.
Afshari AR; Motamed-Sanaye A; Sabri H; Soltani A; Karkon-Shayan S; Radvar S; Javid H; Mollazadeh H; Sathyapalan T; Sahebkar A
Curr Med Chem; 2021; 28(24):4877-4892. PubMed ID: 33441062
[TBL] [Abstract] [Full Text] [Related]
7. Safety and efficacy of targeted alpha therapy with
Królicki L; Bruchertseifer F; Kunikowska J; Koziara H; Królicki B; Jakuciński M; Pawlak D; Apostolidis C; Mirzadeh S; Rola R; Merlo A; Morgenstern A
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):614-622. PubMed ID: 30498897
[TBL] [Abstract] [Full Text] [Related]
8. Application of neurokinin-1 Receptor in Targeted Strategies for Glioma treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with
Majkowska-Pilip A; Koźmiński P; Wawrzynowska A; Budlewski T; Kostkiewicz B; Gniazdowska E
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301182
[TBL] [Abstract] [Full Text] [Related]
9. Plasma neurokinin A Levels Predict Survival in Well-Differentiated Neuroendocrine tumors of the Small Bowel.
Woltering EA; Voros BA; Thiagarajan R; Beyer DT; Ramirez RA; Wang YZ; Mamikunian G; Boudreaux JP
Pancreas; 2018 Aug; 47(7):843-848. PubMed ID: 29939909
[TBL] [Abstract] [Full Text] [Related]
10. In vitro evaluation of
Majkowska-Pilip A; Rius M; Bruchertseifer F; Apostolidis C; Weis M; Bonelli M; Laurenza M; Królicki L; Morgenstern A
Chem Biol Drug Des; 2018 Jul; 92(1):1344-1356. PubMed ID: 29611298
[TBL] [Abstract] [Full Text] [Related]
11. Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the neurokinin-1 Receptor System.
Berger M; VON Schweinitz D
Anticancer Res; 2017 Nov; 37(11):5911-5918. PubMed ID: 29061769
[TBL] [Abstract] [Full Text] [Related]
12. Development of a Ligand-Targeted Therapeutic Agent for neurokinin-1 Receptor Expressing Cancers.
Kanduluru AK; Low PS
Mol Pharm; 2017 Nov; 14(11):3859-3865. PubMed ID: 28969417
[TBL] [Abstract] [Full Text] [Related]
13. β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G
Zhang YX; Li XF; Yuan GQ; Hu H; Song XY; Li JY; Miao XK; Zhou TX; Yang WL; Zhang XW; Mou LY; Wang R
J Biol Chem; 2017 May; 292(21):8933-8947. PubMed ID: 28341744
[TBL] [Abstract] [Full Text] [Related]
14. [Basic and translational research progress of gastrointestinal neuroendocrine neoplasmas].
Song Y; Li X; Song T; Lin G; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1217-1221. PubMed ID: 27928788
[TBL] [Abstract] [Full Text] [Related]
15. Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors.
Zhang Y; Li X; Li J; Hu H; Miao X; Song X; Yang W; Zeng Q; Mou L; Wang R
Peptides; 2016 Sep; 83():8-15. PubMed ID: 27458061
[TBL] [Abstract] [Full Text] [Related]
16. Targeted Radiolabeled Compounds in Glioma Therapy.
Cordier D; Krolicki L; Morgenstern A; Merlo A
Semin Nucl Med; 2016 May; 46(3):243-9. PubMed ID: 27067505
[TBL] [Abstract] [Full Text] [Related]
17. Management of Chemotherapy Induced Nausea and Vomiting in Patients on Multiday Cisplatin Based Combination Chemotherapy.
Ranganath P; Einhorn L; Albany C
Biomed Res Int; 2015; 2015():943618. PubMed ID: 26425563
[TBL] [Abstract] [Full Text] [Related]
18. Raised circulating neurokinin A predicts prognosis in metastatic small bowel neuroendocrine tumours. Lowering neurokinin A indicates improved prognosis.
Ardill JE; McCance DR; Stronge WV; Johnston BT
Ann Clin Biochem; 2016 Mar; 53(Pt 2):259-64. PubMed ID: 26038607
[TBL] [Abstract] [Full Text] [Related]
19. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Kast RE; Karpel-Massler G; Halatsch ME
Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
[TBL] [Abstract] [Full Text] [Related]
20. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
[TBL] [Abstract] [Full Text] [Related]
[Next]
